von Vigier RO - Search Results

1

A simplified antihypertensive drug regimen does not ameliorate control of childhood hypertension.

Foglia CF, von Vigier RO, Fossali E, Salice P, Ghiglia S, Ardissino G, Pollini I, Bianchetti MG. Foglia CF, et al. Among authors: von vigier ro. J Hum Hypertens. 2005 Aug;19(8):653-4. doi: 10.1038/sj.jhh.1001870. J Hum Hypertens. 2005. PMID: 15905892 No abstract available.

2

How good is blood pressure control among treated hypertensive children and adolescents?

Sieber US, von Vigier RO, Sforzini C, Fossali E, Edefonti A, Bianchetti MG. Sieber US, et al. Among authors: von vigier ro. J Hypertens. 2003 Mar;21(3):633-7. doi: 10.1097/00004872-200303000-00031. J Hypertens. 2003. PMID: 12640259

3

[Arterial hypertension in childhood and adolescence].

von Vigier RO, Bianchetti MG. von Vigier RO, et al. Ther Umsch. 1999 Jan;56(1):12-8. doi: 10.1024/0040-5930.56.1.12. Ther Umsch. 1999. PMID: 10067129 Review. German.

4

Antihypertensive efficacy of amlodipine in children with chronic kidney diseases.

von Vigier RO, Franscini LM, Bianda ND, Pfister R, Casaulta Aebischer C, Bianchetti MG. von Vigier RO, et al. J Hum Hypertens. 2001 Jun;15(6):387-91. doi: 10.1038/sj.jhh.1001203. J Hum Hypertens. 2001. PMID: 11439313

5

Effectiveness and safety of the angiotensin II antagonist irbesartan in children with chronic kidney diseases.

Franscini LM, Von Vigier RO, Pfister R, Casaulta-Aebischer C, Fossali E, Bianchetti MG. Franscini LM, et al. Among authors: von vigier ro. Am J Hypertens. 2002 Dec;15(12):1057-63. doi: 10.1016/s0895-7061(02)03083-2. Am J Hypertens. 2002. PMID: 12460701

6

"What goes up must immediately come down!" Which indication for short-acting nifedipine in children with arterial hypertension?

Calvetta A, Martino S, von Vigier RO, Schmidtko J, Fossali E, Bianchetti MG. Calvetta A, et al. Among authors: von vigier ro. Pediatr Nephrol. 2003 Jan;18(1):1-2. doi: 10.1007/s00467-002-1010-3. Epub 2002 Nov 14. Pediatr Nephrol. 2003. PMID: 12520323 No abstract available.

7

Cyclosporin enhances the tendency towards oedema and flushing noted on dihydropyridine calcium channel blockers.

von Vigier RO, Fossali E, Edefonti A, Vogt B, Bianchetti MG. von Vigier RO, et al. Br J Clin Pharmacol. 2002 Sep;54(3):334-5. doi: 10.1046/j.1365-2125.2002.01622.x. Br J Clin Pharmacol. 2002. PMID: 12236856 Free PMC article. No abstract available.

8

Candesartan cilexetil in children with hypertension or proteinuria: preliminary data.

Simonetti GD, von Vigier RO, Konrad M, Rizzi M, Fossali E, Bianchetti MG. Simonetti GD, et al. Among authors: von vigier ro. Pediatr Nephrol. 2006 Oct;21(10):1480-2. doi: 10.1007/s00467-006-0144-0. Epub 2006 Jun 27. Pediatr Nephrol. 2006. PMID: 16802178 Free article. Clinical Trial.

9

Better renoprotective effect of angiotensin II antagonist compared to dihydropyridine calcium channel blocker in childhood.

Gartenmann AC, Fossali E, von Vigier RO, Simonetti GD, Schmidtko J, Edefonti A, Bianchetti MG. Gartenmann AC, et al. Among authors: von vigier ro. Kidney Int. 2003 Oct;64(4):1450-4. doi: 10.1046/j.1523-1755.2003.00238.x. Kidney Int. 2003. PMID: 12969165 Free article. Clinical Trial.

10

[Hemolytic uremic syndrome in childhood: not so rare in Swiss children].

Fontana M, von Vigier RO, Rudin C, Bianchetti MG. Fontana M, et al. Among authors: von vigier ro. Rev Med Suisse. 2005 Mar 30;1(13):911-4, 916. Rev Med Suisse. 2005. PMID: 15895934 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters